EPSTEIN-BARR VIRUS ROLE IN ONCOGENESIS

Cover Page

Cite item

Full Text

Abstract

We now recognize that the Epstein-Barr virus (EBV) plays a pivotal role in the development of some lymphomas and lymphoproliferative disorders that include B-cell, T-cell and NK-cell processes, and epithelial and mesenchymal tumors. While over recent years, EBV associated lymphomas are becoming increasingly recognized in patients without overt immunodeficiency. Improved understanding of the biology of these lymphomas and the role that EBV plays in their pathogenesis has paved the way for improved therapies targeted at critical signaling pathways as well as the development of novel cellular therapies. This review discusses the unique cytomorphology, clinical and immunophenotype signs and ancillary studies required to diagnose EBV-related neoplasms.

References

  1. Primary CNS lymphoma in HIV positive and negative patients: comparison of clinical characteristics, outcome and prognostic factors / S. Bayraktar [et al.] // J Neurooncol. - 2011. - Vol. 101, №2. -P. 257-265.
  2. Treatment and niology of Lymphomatoid Granulomatosis / B.H. Bird [et al.] // JCO. - 2007. - Vol. 25, №18S (Suppl.). - P. 8029. - (In: ASCO Annual Meeting Proceedings, 2007. Part I).
  3. Cytology: Diagnostic Principles and Clinical Correlates / eds.: E. Cibas, B. Ducatman. - 3rd ed. - Philadelphia: Saunders Elsevier, 2009.
  4. Hodgkin’s lymphoma: diagnostic difficul ties in fine-needle aspiration cytology / D.K. Das [et al.] // Diagn Cytopathol. -2009. - Vol. 37. - P. 564-573.
  5. Epstein-Barr virus-associated tumors: an update for the attention of the working pathologist / H. Delecluse [et al.] // J Clin Pathol. - 2007. - Vol. 60. - P. 1358-1364.
  6. Dogan A. Angioimmunoblastic T-cell lymphoma / A. Dogan, A.D. Attygalle, C. Kyriakou // Br J Haematol. - 2003. -Vol. 121, № 5. - P. 681-691.
  7. MYC+Aggressive B-cell lymphomas: Novel therapy of untreated Burkitt lymphoma (BL) and MYC+Dffuse Large B-cell lymphoma (DLBCL) with DAEPOCH-R / K. Dunleavy [et al.] // Ann Oncol. - 2011. - Vol. 22 (Suppl. 4). - Abstract 071.
  8. Post-transplantation lymphoproliferative disorders: diagnosis, prognosis, and current approaches to therapy / A.M. Evens [et al.] // Curr Oncol Rep. - 2010. - Vol. 12, № 6. - P. 383-394.
  9. Gerstner E. Primary nervous system lymphoma / E. Gerstner, T. Batchelor // Arch Neurol. - 2010. - Vol. 67. - P. 291-297.
  10. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis / eds.: A. Arvin [et al.]. - Cambridge: Cambridge University Press, 2007. - 1432 p.
  11. Efficacy of L-asparaginase with methotrexate and dexamethasone regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study / A. Jaccard [et al.] // Blood. - 2011. - Vol. 117, № 6. - P. 1834-1839.
  12. Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation / O. Landgren [et al.] // Blood. - 2009. - Vol. 113, №20. -P. 4992-5001.
  13. Myopericytoma in patients with AIDS: a new class of Epstein-Barr virusassociated tumor / P. Lau [et al.] // Am J Surg Pathol. - 2009. - Vol. 33. - P. 1666-1672.
  14. Naresh K. Lymphoproliferative disorders in the immunosuppressed / K. Naresh // Diagn Histopathol. - 2009. - Vol. 16. -P. 206-215.
  15. Nodal presentation of nasal-type NK/Tcell lymphoma: report of two cases with fine needle aspiration cytology findings / W.K. Ng [et al.] // Acta Cytol. - 2003. -Vol. 47. - P. 1063-1068.
  16. Pantanowitz L. Clinical history of HIV infection may be misleading in cyto-pathology / L. Pantanowitz, M. Kuperman, R. Goulart // Cytojournal. - 2010. -Vol. 7. -P. 7.
  17. Pattle S. The role of Epstein-Barr virus in cancer / S. Pattle, P. Farrell // Expert Opin Biol Ther. - 2006. - Vol. 6. -P. 1193-1205.
  18. AIDS-related EBV-associated smooth muscle tumors: a review of 64 published cases / B. Purgina [et al.] // Patholog Res Int. - 2011. - Vol. 10. - P. 561-548.
  19. Rezk S. Epstein-Barr virus-associated lymphoproliferative disorders / S. Rezk, L. Weiss // Hum Pathol. - 2007. - Vol. 38. - P. 1293-1304.
  20. Roschewski M. EBV-associated lymphomas in adults / M. Roschewski, W.H. Wilson // Best Pract Res Clin Haematol. - 2012. - Vol. 25, № 1. - P. 75-89.
  21. Saha A. Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clini cal outcomes / A. Saha, E.S. Robertson // Clin Cancer Res. - 2011. - Vol. 17, №10. - P. 3056-3063.
  22. Age-related EBV-associated B-cell lymphoproliferative disorders: diagnostic approach to a newly recognised clinico-pathologic entity / Y. Shimoyama [et al.] // Pathol Int. - 2009. - Vol. 59. -P. 835-843.
  23. Burkitt lymphoma / E.B. Stelow [et al.] // Diagn Cytopathol. - 2008. - Vol. 36. - P. 172-173.
  24. WHO classification of tumours of haematopoietic and lymphoid tissues / S.H. Swerdlow [et al.]. - Lyon: IARC, 2008.
  25. IG/MYC rearrangements are the main cytogenetic alteration in plasmblastic lymphomas / A. Valera [et al.] // Am J Surg Pathol. - 2010. - Vol. 34, № 11. -P. 1686-1694.
  26. Wolfe F. Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observationnal study / F. Wolfe, K. Michaud // Arthritis Rheum. - 2007. - Vol. 56, №9. -P. 2886-2895.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2014 Shestakova I.V., Yushyuk N.D.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
 


Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).